Cargando…

Web-based decision-making tool for smoking cessation (Pare de fumar conosco) among patients with chronic conditions in Brazil : one-arm feasibility study

OBJECTIVE: To assess the feasibility of Pare de fumar conosco, a web-based smoking cessation decision-making tool, among patients with chronic conditions in Brazil. METHODS: We recruited 85 Brazilian smokers in two clinical centres for chronic conditions to complete Pare de fumar conosco. Outcome me...

Descripción completa

Detalles Bibliográficos
Autores principales: Cupertino, Ana Paula, Cartujano-Barrera, Francisco, Basile Colugnati, Fernando Antonio, Batista Formagini, Taynara Dutra, Garcia de Siqueira Galil, Arise, Ferreira Carvalho Banhato, Eliane, Ferreira, Marilda Aparecida, Richter, Kimber P
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7062353/
https://www.ncbi.nlm.nih.gov/pubmed/31915181
http://dx.doi.org/10.1136/bmjhci-2019-100063
_version_ 1783504517602476032
author Cupertino, Ana Paula
Cartujano-Barrera, Francisco
Basile Colugnati, Fernando Antonio
Batista Formagini, Taynara Dutra
Garcia de Siqueira Galil, Arise
Ferreira Carvalho Banhato, Eliane
Ferreira, Marilda Aparecida
Richter, Kimber P
author_facet Cupertino, Ana Paula
Cartujano-Barrera, Francisco
Basile Colugnati, Fernando Antonio
Batista Formagini, Taynara Dutra
Garcia de Siqueira Galil, Arise
Ferreira Carvalho Banhato, Eliane
Ferreira, Marilda Aparecida
Richter, Kimber P
author_sort Cupertino, Ana Paula
collection PubMed
description OBJECTIVE: To assess the feasibility of Pare de fumar conosco, a web-based smoking cessation decision-making tool, among patients with chronic conditions in Brazil. METHODS: We recruited 85 Brazilian smokers in two clinical centres for chronic conditions to complete Pare de fumar conosco. Outcome measures included interest in using smoking cessation resources and self-reported 7-day point prevalence abstinence 12 weeks following the intervention. RESULTS: The average age of participants was 54.2 years old (SD=10.5) and 77.9% had not completed high school. All participants were daily smokers and the majority smoked ≥11 cigarettes per day (63.5%). Pre–post intervention interest in using pharmacotherapy and group counselling significantly increased (82.4% vs 22.4%, p≤0.0001; and 85.9% vs 21.2%, p≤0.0001, respectively). At 12 weeks, eight participants (9.4%) reported 7-day point prevalence abstinence using intention-to-treat analysis (35.2% follow-up rate). CONCLUSION: The Pare de fumar conosco smoking cessation web-based tool significantly increased interest in pharmacotherapy and behavioural counselling. Additional testing as a formal randomised clinical trial appears warranted.
format Online
Article
Text
id pubmed-7062353
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher BMJ Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-70623532020-09-30 Web-based decision-making tool for smoking cessation (Pare de fumar conosco) among patients with chronic conditions in Brazil : one-arm feasibility study Cupertino, Ana Paula Cartujano-Barrera, Francisco Basile Colugnati, Fernando Antonio Batista Formagini, Taynara Dutra Garcia de Siqueira Galil, Arise Ferreira Carvalho Banhato, Eliane Ferreira, Marilda Aparecida Richter, Kimber P BMJ Health Care Inform Short Report OBJECTIVE: To assess the feasibility of Pare de fumar conosco, a web-based smoking cessation decision-making tool, among patients with chronic conditions in Brazil. METHODS: We recruited 85 Brazilian smokers in two clinical centres for chronic conditions to complete Pare de fumar conosco. Outcome measures included interest in using smoking cessation resources and self-reported 7-day point prevalence abstinence 12 weeks following the intervention. RESULTS: The average age of participants was 54.2 years old (SD=10.5) and 77.9% had not completed high school. All participants were daily smokers and the majority smoked ≥11 cigarettes per day (63.5%). Pre–post intervention interest in using pharmacotherapy and group counselling significantly increased (82.4% vs 22.4%, p≤0.0001; and 85.9% vs 21.2%, p≤0.0001, respectively). At 12 weeks, eight participants (9.4%) reported 7-day point prevalence abstinence using intention-to-treat analysis (35.2% follow-up rate). CONCLUSION: The Pare de fumar conosco smoking cessation web-based tool significantly increased interest in pharmacotherapy and behavioural counselling. Additional testing as a formal randomised clinical trial appears warranted. BMJ Publishing Group 2020-01-07 /pmc/articles/PMC7062353/ /pubmed/31915181 http://dx.doi.org/10.1136/bmjhci-2019-100063 Text en © Author(s) (or their employer(s)) 2020. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/.
spellingShingle Short Report
Cupertino, Ana Paula
Cartujano-Barrera, Francisco
Basile Colugnati, Fernando Antonio
Batista Formagini, Taynara Dutra
Garcia de Siqueira Galil, Arise
Ferreira Carvalho Banhato, Eliane
Ferreira, Marilda Aparecida
Richter, Kimber P
Web-based decision-making tool for smoking cessation (Pare de fumar conosco) among patients with chronic conditions in Brazil : one-arm feasibility study
title Web-based decision-making tool for smoking cessation (Pare de fumar conosco) among patients with chronic conditions in Brazil : one-arm feasibility study
title_full Web-based decision-making tool for smoking cessation (Pare de fumar conosco) among patients with chronic conditions in Brazil : one-arm feasibility study
title_fullStr Web-based decision-making tool for smoking cessation (Pare de fumar conosco) among patients with chronic conditions in Brazil : one-arm feasibility study
title_full_unstemmed Web-based decision-making tool for smoking cessation (Pare de fumar conosco) among patients with chronic conditions in Brazil : one-arm feasibility study
title_short Web-based decision-making tool for smoking cessation (Pare de fumar conosco) among patients with chronic conditions in Brazil : one-arm feasibility study
title_sort web-based decision-making tool for smoking cessation (pare de fumar conosco) among patients with chronic conditions in brazil : one-arm feasibility study
topic Short Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7062353/
https://www.ncbi.nlm.nih.gov/pubmed/31915181
http://dx.doi.org/10.1136/bmjhci-2019-100063
work_keys_str_mv AT cupertinoanapaula webbaseddecisionmakingtoolforsmokingcessationparedefumarconoscoamongpatientswithchronicconditionsinbrazilonearmfeasibilitystudy
AT cartujanobarrerafrancisco webbaseddecisionmakingtoolforsmokingcessationparedefumarconoscoamongpatientswithchronicconditionsinbrazilonearmfeasibilitystudy
AT basilecolugnatifernandoantonio webbaseddecisionmakingtoolforsmokingcessationparedefumarconoscoamongpatientswithchronicconditionsinbrazilonearmfeasibilitystudy
AT batistaformaginitaynaradutra webbaseddecisionmakingtoolforsmokingcessationparedefumarconoscoamongpatientswithchronicconditionsinbrazilonearmfeasibilitystudy
AT garciadesiqueiragalilarise webbaseddecisionmakingtoolforsmokingcessationparedefumarconoscoamongpatientswithchronicconditionsinbrazilonearmfeasibilitystudy
AT ferreiracarvalhobanhatoeliane webbaseddecisionmakingtoolforsmokingcessationparedefumarconoscoamongpatientswithchronicconditionsinbrazilonearmfeasibilitystudy
AT ferreiramarildaaparecida webbaseddecisionmakingtoolforsmokingcessationparedefumarconoscoamongpatientswithchronicconditionsinbrazilonearmfeasibilitystudy
AT richterkimberp webbaseddecisionmakingtoolforsmokingcessationparedefumarconoscoamongpatientswithchronicconditionsinbrazilonearmfeasibilitystudy